Join us next Thursday for the latest installment of our "Doing Business in the United States" webinar series, presented in partnership with the #EEN and the European Commission. With the help of our experts - Edward (Ned) Meagher, GEOFFROY JEROME, John Joshua, RRT, MHA - gain comprehensive insights into: ➡️the US #MedTech and #BioTech sectors, providing insights into the unique aspects of the US #lifescience market compared to the EU, key players and engagement strategies for European companies ➡️important legal issues, patent and IP considerations, the #FDAapproval process, business operations in the US market, routes for market entry, funding challenges and opportunities, venture funding strategies ➡️how to navigate the US #healthSystem market. Stream the session live on YouTube https://ow.ly/MBVN50Si8fH or participate through Webex to interact with our experts! https://ow.ly/jMg050Si8fv Don't miss out on this opportunity to gain essential knowledge and unlock new possibilities in the US market. Program coordinated by the EACC New York [European American Chamber of Commerce] and moderated by Yvonne Bendinger 💡For more information: https://ow.ly/hy7G50Si9El #EACCTX EACC New York [European American Chamber of Commerce] EACC Carolinas - European American Chamber of Commerce - Carolinas Erin McKelvey European Innovation Council and SMEs Executive Agency (EISMEA) THOⓂ️AS STEIERT Carter, DeLuca & Farrell LLP Cilcare Northwell Health #lifescience Fernanda Sieverling Victoria Meagher
European American Chamber of Commerce Texas’ Post
More Relevant Posts
-
Exciting News from #OCTMunich Event! 🌐 Join us as Joanna Wilińska, PhD and Andreas Beust take center stage, representing GCPS at the OCT Munich Conference. 🚀 Don't miss the opportunity to attend Andreas Beust exclusive session on "Real World Evidence: The Key to Easy Regulatory Compliance?" Let's make connections, share knowledge, and have a blast together! See you there! #MedDevicesEurope #MedicalDevicesEurope #ClinicalTrials #ClinicalResearch #MedicalDevices
-
-
Beryl Elites 5th Annual Alternative Investments conference NYC, November 6-7, is happening now: PANEL - The Convergence of Tech, AI & ML and other Breakthrough Advancements in Healthcare & Lifesciences: The ongoing transformation has created exciting investment opportunities. Explore market trends, investment strategies, regulatory hurdles, and future prospects as we had into 2024. Discover intricacies of investing in Healthcare & Lifesciences and get the answers from our panel experts featuring: Chris Raphaely, Co-Chair, Health Law Department - Cozen O'Connor Jonathan Brayman, Principal - Blackstone Charles Boorady, Managing Partner - Health Catalyst Capital (HCC) Michael Ludwig, Partner - MTS Health Partners Dominic Carazza, Managing Director - Berkery, Noyes & Co., LLC For details about the 2023 AGENDA and our impressive lineup of speakers, visit our conference page. https://lnkd.in/eYN_-GNN To discover more and participate at Beryl Elites conferences, please click here to REGISTER https://lnkd.in/eYVwfUMq To discover more and participate at Beryl Elites conferences, please click here to REGISTER https://lnkd.in/eYVwfUMq Stay informed about global financial markets, receive updates and be the first to know about our future conference on June 24-25, 2024 by clicking “Follow” on this page. #investments #healthcate #lifesciences #AlternativeInvestments #privateequity
-
-
🌟 Excited to Share Cilcare’s experience in doing business in the US ! 🌟 I had the pleasure of participating in the ‘Embracing #GlobalMarkets’ webinar, developed by the EACC New York [European American Chamber of Commerce] for the Enterprise Europe Network (#EENcanhelp). Together with John Joshua, RRT, MHA (Northwell Health) and @Edward (Ned) Meagher (Carter, DeLuca & Farrell LLP), we delved into key topics essential for navigating the US life sciences ecosystem and doing business in the United States. This comprehensive discussion provided insights for anyone looking to enter or expand within the US market. One take-home message ? Understanding the key players, the market differences between the EU and the US, and the essentials of government agencies are pivotal. Additionally, knowing the routes for market entry, the Patent & IP landscape, the FDA approval process, and the avenues for funding—including raising venture capital—are critical for success. Engaging effectively with US health systems and comprehending their interests and processes can significantly enhance your market entry and growth strategies. A big thank you to my fellow speakers and to everyone who joined us! @Thomas Steiert (Eismea) Yvonne Bendinger-Rothschild #LifeSciences #BusinessDevelopment #USMarket #HealthCareInnovation #FDA #Patents #Funding #WebinarSeries #EENcanhelp #EACCNY
JOIN US TODAY! June 20th (#Webinar) | "Doing business in the United States: What You Need to Know About the #US #LifeSciences Ecosystem" This is the next episode in our webinar series ‘Embracing #GlobalMarkets’, which is a specialty workshop series developed by the European American Chamber of Commerce for the Enterprise Europe Network (#EENcanhelp). You will learn about: 👉 Who are the players and best ways to engage with them 👉 Market differences between EU & the U.S. 👉 Key things you need to know about government agencies 👉 Routes for US market entry 👉 What you need to know about Patent & IP, and the FDA approval Process? 👉 Access to funding in the US life science market 👉 How, when and where to raise venture or other funding 👉 Engaging/partnering with #US #HealthSystems 👉 Main areas of interest for US Health Systems 👉 US health system process for evaluating companies, typical intake process #STREAM the webinar LIVE here: https://lnkd.in/dBHUzJDU or #JOIN the session via WEBEX to interact with our experts: https://lnkd.in/dCXy54gX Jérome Geoffroy (Cilcare) John Joshua, RRT, MHA (Northwell Health) Edward (Ned) Meagher (Carter, DeLuca & Farrell LLP) EACC Carolinas - European American Chamber of Commerce - Carolinas European American Chamber of Commerce Texas
-
-
With clinical development being a high-stakes endeavor, it's important that sponsors and their clinical research partners develop a relationship that goes beyond the transactional. In a new blog, Matt Gallant, Senior Director of Strategic Resourcing Business Development, shares insight on how to maximize clinical research partnerships. Read more: https://hubs.la/Q0242FSP0 #clinicalresearch #strategicresourcing #clinicaloutsourcing
-
-
Ready for Knowledge for Growth in Antwerp tomorrow! Come and visit our team booth #56 Stijn Otte, Frederique Van de Velde and Sema Kaya will be delighted to discuss about your clinical projects! See you there! #knowledgeforgrowth #clinicalresearch #clinicalcro #clinicaloperations
-
-
Rosalie Filling is a patient and clinical site advocate. Watch the below video to find out why it's important for pharmaceutical companies to evolve their #clinicalsites relationships and how to make meaningful strides forward with a few first steps. #EndoProud #clinicialtrials
In the dynamic landscape of clinical trials, the importance of clinical research sites cannot be understated. At YPrime’s Innovation Network Gathering, Rosalie Filling, Vice President and Senior Global Head of R&D Operations at Endo International, shed light on the significance of sites—offering her perspective as both an industry professional and a clinical trial participant. More here: https://hubs.ly/Q02r1T4W0
-
We asked CEO Mark Scullion about the areas of support most important to a partnership with Atlas Clinical Research, and he emphasizes the value in both strategical and operational contributions. To help our investment companies reach their goals, our teams ensure a cultural fit before all else to align on common principles. Listen more below. #patientcare #clinicalresearch #privateequity
-
Thriving or surviving? Stimulating discussion on what industry success means at the Phacilitate Europe plenary talk, chaired by Anthony Davies. Clinical trial activity is an important metric- but ultimately it’s commercial approvals that count! #AdvancedTherapiesEurope #ate23
-
-
🎉 Exciting Milestone for Diagnexia! 🎉 We're honoured to share our selection as a finalist for the Medtech Company of the Year Award at the Medtech Ireland Awards. This prestigious nomination is not just a recognition of Diagnexia's commitment to advancing healthcare technology but also a celebration of our relentless pursuit of excellence in digital pathology. At Diagnexia, we pride ourselves on being your global digital pathology department, providing rapid, expert-driven diagnostic services that are transforming patient care. Our approach is grounded in: Speed: We ensure a swift turnaround, with primary diagnostic reports in 3-5 days and secondary consults in 7-10 days, helping to clear backlogs and reduce workloads. Compliance and Expertise: Each pathologist in our network is a leader in their field, ensuring diagnostic excellence. We're regulated by the Care Quality Commission and meet all ISO27001 standards for information security management. Ease and Accessibility: With Diagnexia, cases can be onboarded, accessed, and monitored from anywhere, simplifying the process for healthcare providers. Join us at #MedtechRising, where we'll delve into the future of healthcare alongside industry leaders, exploring topics from AI to sustainability. It’s an opportunity to see how Diagnexia and others are shaping the medtech landscape with innovation and excellence. #MedtechRising2023 #DigitalPathology #HealthcareInnovation #MedtechAwards #Diagnexia
Congratulations to Medtech Company of the Year Award finalists: - Arrotek Medical Ltd - Diagnexia - TriMedika Dr Eoghan Ó Faoláin, Irish Medtech Association, Director, said, “The Irish Medtech Award mark an annual celebration of our global hub and I am proud to reveal this year’s finalists today. The winners will be announced at Medtech Rising, 7 December, in The Galmont Galway. This must attend attracts 500 business leaders annually with the Business Leaders’ Conference preceding the black tie ceremony." "This year’s event will explore: worldclass innovation, global economic outlook, sustainability, fostering talent, generative AI, the future of EU regulations, and more. Bringing senior business leaders together with key opinion leaders, and policymakers is vital to ensure that the industry here has the foresight needed to achieve its ambition of transforming lives with innovative patient-centred medtech.” Book #MedtechRising here: https://lnkd.in/emU76Mm
-
-
It has been an important week for Accord Healthcare, marked by our participation in the Global Investment Summit. Represented by our EVP, Paul Tredwell, we joined an influential gathering of over 200 CEOs, investors, and leaders from the UK’s science, tech, and creative sectors. This summit, hosted by the UK Government, was a significant platform for discussing the future of investment in these vital industries and highlighting the challenges. The event was a prime opportunity for industry leaders like Accord to engage in high-level discussions, gaining insights into the evolving landscape of investment in the UK. It offered a forum for exchanging ideas and deliberating on strategies among attendees, aiming to enhance the UK's position as an attractive destination for investment, especially for leading manufacturers. Paul's participation underscores our commitment to being at the forefront of these conversations, actively shaping a more investable future for the UK. We are excited about the possibilities this summit has highlighted and look forward to ongoing dialogue on how we foster an environment that supports future inward investment. #pharmaceuticalinnovation #GIS23 (S)
-